• Profile
Close

A systematic review of atypical antipsychotics in chronic pain management: Olanzapine demonstrates potential in central sensitization, fibromyalgia, and headache/migraine

The Clinical Journal of Pain May 24, 2018

Jimenez XF, et al. - Researchers performed a systematic review of all studies examining atypical antipsychotics (AAs) use for pain. They used 3 literature databases to search for word combinations of “pain” and a variety of commonly prescribed AAs ie, (olanzapine, quetiapine, risperidone, aripiprazole, ziprasidone, clozapine, paliperidone, iloperidone, lurasidone) and recognized only a few studies evaluating the analgesic effects of AAs. In multiple studies evaluating olanzapine in pain syndromes, preliminary and consistent efficacy of olanzapine in fibromyalgia and headache/migraine was noted. Other AAs eg, (quetiapine) failed to demonstrate efficacy in pain syndromes and/or lack robust study designs.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay